Co-Authors
This is a "connection" page, showing publications co-authored by Hai-Nan Zhang and Shu-Juan Guo.
Connection Strength
0.468
-
Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins. Acta Biochim Biophys Sin (Shanghai). 2021 Aug 31; 53(9):1134-1141.
Score: 0.060
-
Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy. Cell Discov. 2021 Aug 17; 7(1):67.
Score: 0.060
-
Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins. Cell Rep. 2021 07 13; 36(2):109391.
Score: 0.060
-
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients. Cell Rep. 2021 03 30; 34(13):108915.
Score: 0.058
-
Systematic profiling of SARS-CoV-2-specific IgG epitopes at amino acid resolution. Cell Mol Immunol. 2021 04; 18(4):1067-1069.
Score: 0.058
-
Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients. Cell Mol Immunol. 2021 03; 18(3):621-631.
Score: 0.058
-
Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections. Allergy. 2021 02; 76(2):551-561.
Score: 0.057
-
Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients. Cell Mol Immunol. 2020 10; 17(10):1095-1097.
Score: 0.056